• 1
    Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM and The Group Health Medical Personnel. Diminished lung function as a predisposing factor for wheezing respiratory illnesses in infants. N Engl J Med 1988; 319: 11121127.
  • 2
    Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M., Morgan WJ and The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133138.
  • 3
    Stein RT, Holberg CJ, Morgan WJ, Wright AL, Lombardi E., Martinez FD. Peak flow variability and methacholine responsiveness as markers of different wheezing phenotypes in children: a prospective study. Thorax 1997; 52: 946952.
  • 4
    Sigurs N., Bjamason R., Sigurbergsson F., Kjellman B., Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95: 500505.
  • 5
    Groothuis JR, Simoes EA, Levin MJ, et al. and The Respiratory Syncytial Virus Immunoglobulin Study Group. Prophylactic administration of respiratory syncytial virus immunoglobulin to high-risk infants and young children. N Engl J Med 1993; 329: 15241530.
  • 6
    Glczen P., Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288: 498505.
  • 7
    Agertoft L., Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373381.
  • 8
    Yunginger JW, Reed CE, O'Connell EJ, Melton J., O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma. Incidence rates, 1964–1983. Am Rev Respir Dis 1992; 146: 888894.
  • 9
    Holberg CJ, Elston RC, Halonen M., et al. Segregation analysis of physician-diagnosed asthma in Hispanic and non-Hispanic white families. Am J Respir Crit Care Med 1996; 154: 144150.
  • 10
    A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997; 15: 389392.
  • 11
    Singh CF, Haviland MB, Reilly SL. Genetic architecture of common multifactorial diseases. In: Ciba Foundation Symposium 197, Variation in the human genome. Chichester : Wiley, 1996: 211232.
  • 12
    Northway WH, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323: 17931799.
  • 13
    von Mutius E., Nicolai T., Martinez FD. Prematurity as a risk factor for asthma in preadolescent children. J Pediatr 1993; 123: 223229.
  • 14
    Wittig H., Glaser J. Relationship between bronchiolitis and childhood asthma: follow-up study of 100 cases of bronchiolitis in infancy. J Allergy 1959; 30: 1923.
  • 15
    Welliver RC, Wong DT, Sun M., Middleton E., Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305: 841846.
  • 16
    Holgate ST. The cellular and mediator basis of asthma in relation to natural history. Lancet 1997; 350: sII5sII9.
  • 17
    Koller DY, Wojnarowski C., Herkner KR, et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997; 99: 752756.
  • 18
    Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life by subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol 1998; 102: 915920.
  • 19
    Garafalo R., Dorris A., Ahlstedt S., Welliver RC. Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease. Pediatr Allergy Immunol 1994; 5: 111117.